BMS 181165
Alternative Names: BMS 181164Latest Information Update: 16 Jan 2008
At a glance
- Originator Bristol-Myers Squibb
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Varicella zoster virus infections
Most Recent Events
- 05 Aug 1998 No-Development-Reported for Varicella zoster virus infections in USA (Unknown route)